The David H. Koch Institute for Integrative Cancer Research at MITThe David H. Koch Institute for Integrative Cancer Research at MIT

Massachusetts Institute of Technology

National Cancer Institute Cancer Center

Science + Engineering... Conquering Cancer Together

Industry Partnerships

The Koch Institute is outward looking. Industry outreach can take various forms, including collaborations with pharma companies (both institute-wide and one-offs), licensing deals with pharma/biotech, and maximizing impact through start up companies.

A long-term partnership with Janssen Pharmaceuticals, Inc fosters oncology research and technology development in cancer diagnostics (predictive biomarkers, surrogate endpoints, and CTCs), novel therapeutic targets, drug delivery systems, cancer immunotherapies, and murine disease models to study pre-malignancies, tumor progression, and target validation.